Member Info for uinsionn

looks like its getting jiggy here, looks like the seller has cleared, looks like somebody mopped him up earlier, this will rocket from here on newsflow, which is expected from DC, as he pushes this company to the next level

http://twitdoc.com/view.asp?id=458860&sid=9U24&ext=DOCX&lcl=LVCG.docx&usr=AIMRANGER1 investment notes for anyone interested, I think its worth a look as the story is only at the beginning and can see a huge journey here over the coming months

Don't think we are too far off newsflow now, could be new contracts, sponsorship or updates on current events, think we are about to see this story unfold here. need to attend one of these events soon and see the hype for myself, seems uptake on tickets has been huge, but our business model means we don't take the event costs, we are just licensing the events and revenue taking from sponsors and sales, imagine the tie ups that could be done with this business, these captive kids markets are great. selling food and merchandise,

I ACTUALLY cant believe we are still at these levels, we got plenty of news coming and DC is building a real global company and brand here, cant believe that market hasn't woken up to what is going on in this share. building a company on the back of one of the biggest brands in the world LEGO

During his 35 year career, through his innovative vision, drive and creativity, David Ciclitira has played a significant role in shaping today's satellite broadcasting and sponsorship landscape. David read law at Kings College London and was called to the Bar (Barrister) as a Blackstone Exhibitor before joining the merchant bank Guinness, Mahon & Co. He was one of the four original shareholders of Europe's first satellite television station, Satellite Television plc ('SATV'), which was renamed SKY following the sale in 1983 of 65% of SATV to Rupert Murdoch's News Corporation. David remained with Sky as Deputy Managing Director until the end of 1986 when he left to found the original Parallel Media Group ('PMG'). While at Sky Channel, as well as the day to day running of the television station David Ciclitira was responsible for establishing Sky's own production company and for setting up of the first VPL and Pan-European PRS agreements, as well as the conception of, and early involvement in, the setting up of Eurosport. During this time David also established the first ever World Music Video Awards. In 1987, David founded Parallel Media Group plc (PMG) In 1998, under David's guidance PMG entered into a joint venture with NBC for the formation of CNBC Sports International Limited, the international sports broadcasting arm of NBC which was broadcast on its CNBC Europe and CNBC Asia platforms. PMG successfully sold its shareholding in CNBC Sports to NBC in 2004. David Ciclitira is established as one of the major forces in, and respected member of, the global sports marketing industry. Through his strong personal relationships with the commissioners of various sporting federations, proven marketing skills with sponsors and wide-ranging contacts within the broadcasting world,David has revolutionised the sports marketing strategies of some of the world's leading Federations - taking European Tour golf out of Europe and into South Africa and then Asia (including introducing the first professional golf tournament to China at Mission Hills), re-launching the World Cup of Golf and bringing the event under the wing of the Five Tours, representing the World Nordic Ski Championship on behalf of the FIS, overseeing the sponsorship and broadcast strategies of the Davis Cup, raising sponsorship for the first ever Jordan Formula One team with 7Up, representing the commercial rights of the Ladies European Golf Tour, instigating the commercialisation of the English and Italian Rugby Unions, and creating the Tour of China cycling race. David has also overseen the marketing strategies for some of the world's leading brands including managing Pepsi's UK music sponsorship strategy for several years, representing Heineken as its global sponsorship agency (creating the pan-European Buckler Basketball Challenge and overseeing their activities in golf, as well as overseeing their sponsorship of the Whitbread Round the World Yacht Race), acting as Omega's

Looking to good here, looks like it�s on it�s way back down to the low numbers again, sector is really suffering at the moment

�Everything is Awesome� for Lego Lego is the World�s most powerful brand. It scores highly on a wide variety of measures on Brand Finance�s Brand Strength Index such as familiarity, loyalty, promotion, staff satisfaction and corporate reputation. Lego is a uniquely creative and immersive toy; children love the ability to construct their own worlds that it provides. In a tech-saturated world, parents approve of the back-to-basics creativity it encourages and have a lingering nostalgia for the brand long after their own childhoods. The Lego Movie perfectly captured this cross-generational appeal. It was a critical and commercial success, taking nearly US$500m since its release a year ago. It has helped propel Lego from a well-loved, strong brand to the World�s most powerful.

https://www.forbes.com/sites/jeffkauflin/2017/02/14/the-most-powerful-brands-in-2017/#2341b3bf1f84 worlds most powerful brand as ranked, the links with this and the sponsors coming on board, also the focus on major tie ups in the emerging Asian and Chinese markets this company has a global brand behind it, its also building its own huge brand on the back of it. it has already signed permanent contract and is in the early stages of rolling out several other linked events and sponsors

Expect a lot of news flow this month here, with new events and new tie ups, this one is going to be huge, only the start here and 35p as a very solid base. FF is none existent last time volume here it went to 97p in minutes, chart setup say next target 55p, this will build over time as it has all the ingredients of a major business and global brand. would expect we see some major sponsors getting on board here to ride on its back.

Your are correct with the 3 days to notify that doesn�t mean we will get a Rns within 10 working days of the notification - for the sole purpose of clearing and settlement within a settlement cycle not exceeding the period beginning with the transaction and ending at the close of the third trading day following the day of the execution of the transaction (irrespective of whether the transaction is conducted on-exchange); that has to be done for regulation purposes to the company and governing body but market must be informed no later than 10 working days after this declaration, that�s what I have always assumed but could be wrong

From settlement date, think we are just waiting on it being released, we know it probably already has landed on their desk, just acting slowly as usual, sure it will land before the end of this week

I was just thinking a finish over 7p would have been a bullish end to the day looks like its going raging bull as we could finish above 8p, this is well undervalued at price and the company are now turning into a revenue generating business with desirable tech in a key sector with a major on board and the directors in talks with others.

#BioTrinity2018 starts today (a major Bio/Pharma INVESTMENT and PARTNERING conference sponsored by likes of Glaxo , Lilly, Sanofi, Novartis etc etc ) Monday - Partnering meetings Tuesday - Physiomics giving a Company Update Wednesday - Government funding body Innovate UK holding a Presentation on how they plan to invest �0.5-1.5m a pop in projects from SMEs in Precision Medicine

THIS IS WHAT WE NEED TO REMEMBER - Merck deal validates tech 58 potential clients 2 deals imminent Potential deal in Immune-oncology Service Provider collaboration talks Cancer DSS tool with Oxford University Substantial NON-DILUTIVE funding Ex-founder reckons 100p+ directors have kept cashburn low and dilution very low, they have run a tight ship and will want a big reward here for their hard work, they are currently in talks with other potential clients

The Company plans to use the opportunity of the conference to touch base with current clients, all of whom will be represented there, as well as to hold targeted meetings with potential future clients.MEETINS ORGANISED WITH POTENTIAL CLIENTS

only the start here, this is a company that has big plans to grown from last years proof of concept deal with merck put us on the radar to all the big boys, time for some more contracts i think Physiomics helps biotech and pharmaceutical companies to accelerate their pre-clinical and clinical oncology pipelines, by predicting combination efficacy and by determining optimal schedules using the Virtual Tumour in silico model. https://t.co/fT8f5LXlSD

Physiomics are also talking to other potential clients. Several deals are believed to be 'imminent Physiomics plc combines systems biology with cutting edge mathematics to develop models that streamline the drug discovery and development process. Virtual Tumour, the companys lead service, is used to optimise the dosing and scheduling of oncology drugs in pre-clinical trials. This optimisation improves the efficacy of combinations in pre-clinical xenografts. The company is also developing: Virtual Tumour Clinical, to directly predict optimal regimens for human clinical trials.

Potential to improve response and survival rate in the clinic through enhanced drug potency ArrowTransform clinical decision making in terms of dose and schedule ArrowModel the dynamics of tumour size and circulating biomarkers available from individual patients ArrowUnderstand how changes in schedules and doses of drug combinations affect the dynamics of tumour burden

The technology is worth millions more than its lowly share price. Some of you have intimated that 10p is possible At this price it is still so way undervalued as misunderstood it is unbelievable. You cannot begin to imagine how difficult it is to put together the world class team that work at Physiomics and how very few people are capable of modelling in this way. To assemble this team and to possess the very best vascularised tumour models in the world would be described by most industry experts as "phenomenal" as indeed their results. This contract alone and more to follow only serves to underpin their remarkable technology.50 million market cap With apologies this will far exceed this value over time.

Dr Mark Chadwick, CEO of Physiomics, commented: "It is very pleasing that we have further extended the number of large pharmas starting to use Virtual Tumour. We look forward to adding more such customers as the benefits of our model are more widely understood."